Publication date: Dec 22, 2024
Tuberculosis (TB) remains a global health challenge, with 1. 3 million deaths in 2022. Ten countries in the European Union (EU) and European Economic Area (EEA) accounted for 88. 3% of TB cases, of which 23. 8% were from Romania. Evidence shows that mental health issues, decreased quality of life and negative socio-economic impact are common among TB patients; however, there is limited evidence available in Romania. The main aim of this study is to longitudinally assess the quality of life, mental health, and socio-economic status of patients with drug-resistant TB (DR TB) in Romania. A prospective cohort study was conducted at the Marius Nasta Institute of Pneumology in Bucharest, Romania, enrolling 50 participants with DR TB. Demographic data, clinical examinations, laboratory test and medical history were recorded at study start. At baseline (week two), month 10, and month 20 we also administered the Short-Form-36 and Kessler Psychological Distress Scale to assess health-related quality of life and mental health status, and socio-economic questionnaires to 46 participants. Of the 46 participants with median age of 48. 9 years, 71. 7% were males. Majority of the participants were employed at the baseline but due to the rigorous treatment and hospitalization had to take sick leave, thereby affecting the individual and household income. 26. 1% and 39. 3% of participants reported psychological distress at baseline and at the end of month 20, respectively. The quality-of-life scores improved during treatment: PCS with a mean of 67. 0 (SD-33. 9) at baseline, 63. 3 (SD-31. 9) at month 10 and 70. 3 (SD-30. 3) at month 20, and MCS with 62. 8 (SD-30. 6), 67. 8 (SD-29) and 70. 8 (SD-27. 3), accordingly, but differences were not significant. We examined the socio-economic impact, quality of life, and psychological distress among patients affected by DR TB in Romania. The results of this study suggest that social and psychological support will ensure a better standard of living during and following TB treatment.
Semantics
| Type | Source | Name |
|---|---|---|
| pathway | KEGG | Tuberculosis |
| disease | MESH | Tuberculosis |
| disease | MESH | psychological well-being |
| disease | IDO | quality |
| disease | MESH | drug-resistant tuberculosis |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | IDO | history |
| disease | MESH | Psychological Distress |
| disease | MESH | health status |
| drug | DRUGBANK | Tropicamide |